id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-D-4267-0002,FDA,FDA-2018-D-4267,"Draft Guidance for Industry, Biomarker Qualification Evidentiary Framework",Other,Guidance,2018-12-12T05:00:00Z,2018,12,2018-12-12T05:00:00Z,2019-02-12T04:59:59Z,2024-11-12T22:51:59Z,,1,0,0900006483988d4b
FDA-2018-D-4267-0001,FDA,FDA-2018-D-4267,"Biomarker Qualification: Evidentiary Framework; Draft Guidance for
Industry and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2018-12-12T05:00:00Z,2018,12,2018-12-12T05:00:00Z,2019-02-12T04:59:59Z,2019-02-24T17:01:16Z,2018-26900,0,0,090000648398820d